ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Arintra: Revolutionizing Medical Billing with GenAI and $21M New Capital

SAN FRANCISCO, CA / ACCESS Newswire / August 21, 2025 / Arintra, a healthcare technology startup founded by two machine learning PhDs, Nitesh Shroff, Preeti Bhargava, secured $21 million in a Series A funding round led by Peak XV Partners. The company is also backed by Endeavor Health Ventures, Y Combinator, FoundersX Ventures, Counterpart Ventures, Spider Capital, and Ten13. Its innovative AI-native autonomous coding platform transforms revenue cycle management for health systems by integrating autonomous medical coding, clinical documentation improvement (CDI), and payer-aware denial insights directly within electronic health record (EHR) systems -delivering revenue assurance at scale.

Arintra CEO Nitesh Shroff speaking at FoundersX AI Agents Event at TechWeek SF 2024 (Nitesh on the far right, with FoundersX team)

Addressing Healthcare Revenue Challenges

Hospitals face shrinking margins while grappling with unclaimed revenue due to complex coding processes, a shortage of skilled coders, and increasingly stringent payer requirements. Arintra's platform tackles these issues head-on by automating the coding process, ensuring accurate and efficient billing. Unlike many autonomous coding tools that merely convert patient charts into billing codes, Arintra adopts a comprehensive approach to deliver revenue assurance. It focuses on three key pillars:

  • Documenting Services Performed: Capturing complete and accurate clinical documentation.

  • Coding Based on Documentation: Generating precise billing codes that reflect the documented care.

  • Supporting Charged Claims: Providing payer-aware insights to minimize denials and ensure audit-ready claims.

Proven Impact and Customer Success

Arintra's platform has processed over $1 billion in healthcare charges, helping customers recover millions in revenue that would have otherwise been lost. Notable outcomes include:

  • Mercyhealth: Achieved a 5.1% revenue increase and a 43% reduction in claim denials for automated cases. Work-queue aging was halved, and coding costs dropped by 32%.

  • Reid Health (Indiana): Transitioned from billing delays and high denial rates to faster accounts receivable (A/R) and automated charge capture, all without disrupting existing workflows.

With the new funding, Arintra aims to expand coverage across more medical specialties, enhance clinical documentation improvement, and bolster denial analytics. The company also plans to establish a new headquarters in the Bay Area to support its growth. CEO and co-founder Nitesh Shroff, PhD, stated, "Reimbursement is fundamentally broken. Our goal is compliant revenue at scale, without adding burden to clinical or IT teams."

FoundersX Ventures: An Early Believer in Arintra's Vision

FoundersX Ventures, a firm dedicated to pioneering technologies, supported Arintra from its inception, investing in its seed round with firm belief in its potential to transform hospital operations through AI and digital innovation, beginning with medical coding automation. Arintra initially targeted high-demand hospital departments like radiology, with plans to extend its solutions to emergency rooms (ERs) and primary care settings.

Arintra's impact on hospital revenue represents only the beginning of its potential to reshape healthcare operations. "It was eye-opening to learn that most U.S. hospitals operate on just 3% margins while losing 10-15% of revenue to insurance claim rejections, largely due to manual and outdated medical billing systems. Arintra is solving this massive problem with GenAI automation to save our hospitals." said Helen H. Liang, PhD, Managing Partner at FoundersX.

Arintra's AI-driven, end-to-end platform tackles these challenges by automating medical coding, enhancing claim accuracy, and minimizing revenue loss, setting the stage for broader operational improvements across healthcare systems.

About Arintra

Arintra delivers the industry's leading GenAI-native autonomous coding platform, empowering health systems to achieve accurate and efficient reimbursement for their services, ensuring revenue assurance at scale. By integrating advanced AI with deep clinical expertise, Arintra autonomously codes medical charts with high precision, eliminating the need for human intervention. Unlike standalone tools, Arintra seamlessly integrates into electronic health record (EHR) systems, enabling adoption without workflow disruptions or risks to data integrity. Health systems leveraging Arintra recover lost revenue from coding errors, documentation gaps, and unaddressed denials, achieving over 5% revenue uplift, 12%+ reduction in accounts receivable (A/R) days, and 43%+ fewer claim denials.

Media Contact

Arintra
Terri Logan, Manager, Marketing
terri.logan@arintra
Website: https://www.arintra.com/

SOURCE: Arintra



View the original press release on ACCESS Newswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.